Search

everythinglearnresearchcommunity

for

Search:↓

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Cuticapil Stem Hair Serum improves hair growth and reduces shedding when added to minoxidil.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

N-acetyl-L-cysteine (NAC) can prevent DNA damage and protect cells from harm.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Global oil use will rise, US corn-to-ethanol policy is flawed, and various social and economic issues need attention.

Thicker hair grows faster; hair loss patients have slower growth.

Breast cancer patients need strong psychological support to improve their quality of life.